Neurocrine Biosciences shares owned by Envestnet Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Envestnet Asset Management
from 13F filings
Historical chart of Envestnet Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neurocrine Biosciences by Envestnet Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $27M | 234k | 115.22 |
2024-06-30 | $28M | 203k | 137.67 |
2024-03-31 | $28M | 199k | 137.92 |
2023-09-30 | $22M | 193k | 112.50 |
2023-06-30 | $7.8M | 82k | 94.30 |
2023-03-31 | $12M | 407k | 29.39 |
2022-12-31 | $15M | 124k | 119.44 |
2022-09-30 | $13M | 124k | 106.21 |
2022-06-30 | $12M | 126k | 97.48 |
2022-03-31 | $11M | 120k | 93.75 |
2021-12-31 | $7.2M | 85k | 85.17 |
2021-09-30 | $9.4M | 98k | 95.91 |
2021-06-30 | $8.9M | 91k | 97.32 |
2021-03-31 | $8.6M | 89k | 97.25 |
2020-12-31 | $7.7M | 80k | 95.85 |
2020-09-30 | $7.7M | 80k | 96.16 |
2020-06-30 | $5.8M | 47k | 122.01 |
2020-03-31 | $3.8M | 43k | 86.55 |
2019-12-31 | $3.9M | 36k | 107.48 |
2019-09-30 | $3.2M | 35k | 90.11 |
2019-06-30 | $2.6M | 31k | 84.42 |
2019-03-31 | $2.5M | 28k | 88.09 |
2018-12-31 | $1.4M | 20k | 71.39 |
2018-06-30 | $49k | 497 | 98.59 |
2018-03-31 | $34k | 405 | 83.95 |
2017-12-31 | $27k | 352 | 76.70 |
2017-09-30 | $23k | 377 | 61.01 |
2017-06-30 | $35k | 763 | 45.87 |
2017-03-31 | $36k | 843 | 42.70 |
2016-12-31 | $27k | 701 | 38.52 |
2016-09-30 | $53k | 1.0k | 50.91 |
2015-12-31 | $71k | 1.3k | 56.35 |
2015-09-30 | $56k | 1.4k | 39.66 |
2014-09-30 | $999 | 35 | 28.57 |
2014-06-30 | $999 | 35 | 28.57 |
2014-03-31 | $999 | 35 | 28.57 |
More positions owned by Envestnet Asset Management
View all positions for Envestnet Asset Management